Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Hypercholesterolemia
Interventions: Fish Oil, Cinnamon, Garlique,Turmeric, Plant Sterol, Red Yeast Rice, Rosuvastatin, Placebo; Dietary Supplement · Drug · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years to 75 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Retinitis Pigmentosa, X-linked Genetic Diseases
Interventions: docosahexaenoic acid OR corn/soy oil placebo; Drug
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 7 Years to 32 Years · Male only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
Interventions: omega-3 fatty acid; Dietary Supplement
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years to 120 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2004
U.S. locations: 5
States / cities: Wilmington, Delaware • Iowa City, Iowa • Manhasset, New York + 2 more

Conditions: Cardiovascular Diseases, Depression, Heart Diseases, Myocardial Infarction, Angina, Unstable
Interventions: Sertraline/omega-3, Sertraline/Corn Oil; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Overactive Bladder
Interventions: Omega 3 Fatty Acid, Placebo; Drug
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes Mellitus, Diabetic Peripheral Neuropathy, Diabetic Foot Ulcer
Interventions: Lovaza, L-Arginine Powder, Vitamin C; Drug
Lead sponsor: Prisma Health-Midlands; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Autism
Interventions: docosahexaenoic acid (DHA), Placebo; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 3 Years to 10 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Autism
Interventions: Omega 3 fatty acids, Placebo; Drug · Other
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 5 Years to 17 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven IV lipid emulsion; Drug
Lead sponsor: Sivan Kinberg; Other
Eligibility: 2 Months to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Diet Modification, Lung Cancer
Interventions: Special Diet Therapy (low-carb), Special Diet Therapy (low-fat), Special Diet Therapy (USDA control); Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Overweight and Obesity, Hyperandrogenemia, Insulin Resistance
Interventions: Mediterranean-based, carbohydrate restricted, calorie reduced diet; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Cancer Cachexia
Interventions: Eicosapentaenoic Acid; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 25 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Stuart, Florida • Tampa, Florida

Conditions: Hepatitis C
Interventions: Omega-3 Fatty Acids, Placebo comparator; Dietary Supplement · Drug
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Kansas City, Missouri

Conditions: HIV Infections, Heart Disease
Interventions: Lovaza, Placebo; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Total Hip Arthroplasty
Interventions: Fish Oil; Dietary Supplement
Lead sponsor: Jeffrey L Stimac MD; Other
Eligibility: 18 Years to 99 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Obesity, Inflammation, Human Microbiome, Insulin Resistance, Dyslipidemias
Interventions: Omega-3 polyunsaturated fatty acid, High-Intensity Interval Training, Safflower oil, Low-intensity training; Dietary Supplement · Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Obesity
Interventions: SFA, MUFA, PUFA-LA, ALA, LCn3; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven®; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 4 Weeks to 18 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Fatty Liver
Interventions: Polyunsaturated fatty acid (Opti-EPA), Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: T2DM (Type 2 Diabetes Mellitus)
Interventions: Cohort A: ORMD-0801, Placebo oral capsule, Cohort B: ORMD-0801; Drug
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 373 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Huntington Disease
Interventions: Ethyl-EPA (Miraxion™); Drug
Lead sponsor: Amarin Neuroscience Ltd; Industry
Eligibility: 35 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 35
States / cities: Birmingham, Alabama • Scottsdale, Arizona • La Jolla, California + 31 more

Conditions: Anorexia, Cachexia
Interventions: eicosapentaenoic acid, megestrol acetate, placebo; Dietary Supplement · Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 22
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Peoria, Illinois + 19 more

Conditions: Cardiovascular Diseases, Mood Disorders, Inflammation
Interventions: Fish Oil, Soybean Oil (Placebo); Dietary Supplement
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 55 Years
Enrollment: 272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Sleep, Body Composition, Strength, Insulin Sensitivity, Energy Expenditure
Interventions: Whey protein, Omega-3 fatty acids; Dietary Supplement
Lead sponsor: University of Arkansas, Fayetteville; Other
Eligibility: Up to 85 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Search by objective public record fields.

Supplements, Placebo, or Rosuvastatin Study

DHA and X-Linked Retinitis Pigmentosa

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

Oxybutynin and Omega-3 for OAB (Overactive Bladder)

Immunonutrition for Diabetic Foot Ulcers

Docosahexaenoic Acid in the Treatment of Autism

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

Compassionate Use of Omegaven IV Fat Emulsion

Reducing Insulin, Growth Hormones, and Tumors

Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection

Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

Fish Oil in Total Hip Replacement Randomized Clinical Trial

Combining HIIT and n-3 PUFA to Reduce Inflammation and Improve Metabolic Health

Acute Effects of Fats on Satiety and Energy Needs

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior

Nutrition, Body Composition, and Sleep